[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ABEO":3,"homepage-market-summary":29,"stock-news-ABEO":171},{"ticker":4,"date":5,"profile":6,"quote":14},"ABEO","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Abeona Therapeutics Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.","226","Cleveland, OH",{"close":15,"open":16,"high":17,"low":18,"prev_close":17,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},5,5.22,5.25,4.985,-0.25,-4.76,1437451.647215,9130,5.117,5437500,2.19,70118.95353350957,0,11600,{"status":30,"indices":31,"watchlist":73,"sectors":96,"benchmarks":151},"success",[32,40,47,54,60,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":52,"is_up":38,"sparkline":59,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":45,"is_up":38,"sparkline":72,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[74,81,89],{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":38,"sparkline":80,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":87,"sparkline":88,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":87,"sparkline":95,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[97,102,107,112,117,122,127,132,136,141,146],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",1.05,197.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.11,53.46,{"name":108,"etf":109,"change":110,"price":111,"is_up":87},"Healthcare","XLV",-1.32,166.2,{"name":113,"etf":114,"change":115,"price":116,"is_up":87},"Consumer Cycl","XLY",-0.03,108.81,{"name":118,"etf":119,"change":120,"price":121,"is_up":87},"Consumer Staples","XLP",-0.33,80.33,{"name":123,"etf":124,"change":125,"price":126,"is_up":38},"Energy","XLE",1.95,62.7,{"name":128,"etf":129,"change":130,"price":131,"is_up":38},"Industrials","XLI",0.99,168.64,{"name":133,"etf":134,"change":120,"price":135,"is_up":87},"Materials","XLB",48.54,{"name":137,"etf":138,"change":139,"price":140,"is_up":87},"Real Estate","XLRE",-0.56,40.68,{"name":142,"etf":143,"change":144,"price":145,"is_up":38},"Utilities","XLU",0.61,39.68,{"name":147,"etf":148,"change":149,"price":150,"is_up":87},"Comm Services","XLC",-0.93,109.94,[152,157,161,166],{"ticker":153,"name":154,"price":155,"change":156,"is_up":38},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":158,"name":159,"price":160,"change":45,"is_up":38},"QQQ","Invesco QQQ Trust",742.03,{"ticker":162,"name":163,"price":164,"change":165,"is_up":38},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":167,"name":168,"price":169,"change":170,"is_up":38},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"count":172,"articles":173},16,[174,180,186,192,198,204,209,215,221,227,233,237,242,247,252,257],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"Abeona Therapeutics Inc. (ABEO) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE55TTlVMjlTdm9lWE1wVktVdUZyVnF2LUk1MzBaclRyQTRoVVZwVHYyWXVNQ3VJS3lwelNiY1hZdFRUUEp3czVCSHJCS09ZVVN6a3c?oc=5","Thu, 01 Oct 2026 02:10:21 GMT","Abeona Therapeutics Inc. (ABEO) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"Two new hires' awards cover up to 7,200 Abeona shares, which become theirs over three years if they stay. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPUmpETk42Rk1yREp2ZGNGVk5wdzktOEJNYlB2NG1PTEo2X3VXRWFrVlNZMFl3N2NKaVl3eGxjSEJMVlQ0czZ2T3F1SWQ4OXpSQUdYYVVCajNCblo1SUhrdmhGem0xWjFtVV9ZQktDMDY1cGN6bDdUR256UE1VYjBpODBLOGx2X002NmtabTB3RWpKVG42LUVncGt0ZmN6OFZEdXNKaUFQRlF2WUtQeWpITlpobnYzQ0ZTSHR4cXhR?oc=5","Fri, 02 Oct 2026 11:30:00 GMT","Two new hires' awards cover up to 7,200 Abeona shares, which become theirs over three years if they stay. Stock Titan","Stock Titan",{"title":187,"link":188,"pubDate":189,"description":190,"source":191},"Abeona Therapeutics CCO Madhav sells $25,272 in stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOME1CZk5URHJfSW1sSTBLY19Oek1INjBXVTZ4ckhlN2pxbjhUNlJPXy1SZzM1blo3R2JBLUUxTG5RMkcyZjZtZDdVTS02cnV3aWdqajQ4OWJJNFI5QVl2RlUyWE0ydGdWME9rNGdRUDdDanYzN0JoakdJcUdFSUhBbFJnZXcxYWVuczdZVy1XZHVrekRCMTBieGtBUENCdkZRYV83aXNkM25MaXIwSW9BeFZzb2JVMDg?oc=5","Wed, 30 Sep 2026 02:41:20 GMT","Abeona Therapeutics CCO Madhav sells $25,272 in stock Investing.com","Investing.com",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"(ABEO) Volatility Zones as Tactical Triggers - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPY0Q0c0tscmJudUhvd3JzV3RJTDRJRDMxRFRvaVY2Wm5ybldxTFcwQVhIRGJDbno4VjVMcXVrakM4eDNOSXY4b2l4TUVjMzhKYnVBNFQ4UXhodWlnOEl4STJuSGttWWZraU1nUkVQcVNUTFdZWEFtMlgwUlp4OGJNalBOckZIYjdOaGJ0d19EME1uaFp4Y3h4TnFCYkszUmV3S1Q5eTlOTnVoanFZUEJJY1Q0UDhYeWl3TDFhXzF3?oc=5","Sat, 26 Sep 2026 10:06:02 GMT","(ABEO) Volatility Zones as Tactical Triggers Stock Traders Daily","Stock Traders Daily",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"3 Growth Companies With Up To 18% Insider Ownership - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","3 Growth Companies With Up To 18% Insider Ownership Simply Wall Street","Simply Wall Street",{"title":205,"link":206,"pubDate":207,"description":208,"source":185},"To cover stock-award taxes, Abeona Therapeutics (ABEO) legal chief sold 6,727 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPYUJWM1dRMXVoejJaX0R1Q25YREtWaEFucmdVZENTR3QxQUp2SHRNb1pxNi1BUXpJMktnZExQMUxfNmlMc0ljcnptUnhRR3VyUmwyNFZWZHB3QTdxb3pXLXJ4WnBzb0FsSFpzVzNWN0Vkb0FFeWd5QUE2TERlX0dpakdidkxJLWpJcUxwQktRb3B0eUJRank3VjBraHJRRUc0VERPQ0pBTGJHRDcxNTBQWW8wWGt3UXRB?oc=5","Wed, 30 Sep 2026 01:57:18 GMT","To cover stock-award taxes, Abeona Therapeutics (ABEO) legal chief sold 6,727 shares. Stock Titan",{"title":210,"link":211,"pubDate":212,"description":213,"source":214},"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO - FinancialContent","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-AFBVV95cUxQUm9fcnlqUU5HMExRcVhpVk1TZF9MaWx3TEstbENLaVdQbUdiTUtZVUtlTnA3SHVRZE1NZjdUSEhEZFoyVlJLLUZRVUstLWw4ZVpubjFLZUNjNDJ4ZlNFOUh2SldJLXZMYnBFUnlWNzVXT2lQTXQ5ZS1oWjJBT3V6eVQzS1BWelU4ekRXSkRuaHo3ZGF5emo4YmhSendIWDZpdEZxcnh0VklLbC1COFM3MTFlTXF4V21TbkZMc3U5VWF3aXB5bHpOSDlhSTBQcWZPZUN0SHJrR1NGTVJIZGZCR2dGODVMbkRFc0FpZUx0S2x2ZHE4RU1pTQ?oc=5","Tue, 29 Sep 2026 21:43:00 GMT","INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO FinancialContent","FinancialContent",{"title":216,"link":217,"pubDate":218,"description":219,"source":220},"Abeona Therapeutics SVP sells $34,681 in company stock By Investing.com - Investing.com Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxOaURaTnRNQ3NVY2Npb2ZYMkl6b1NBQXQ1WHBmRkl1QjhsWUtFdW1jY0FnWlRjQ3NzN0FWOURVSFVLTU0xV0xGX2xOeGNJV2hURy1XYVVXUkIwQU1aaVF2cHZ6a2dLSi1RU0NuWnRhZlN6LXN6Z2QxbnEzdW9mUmRNU3N2c1g2djEtNS1oYVVlakFxWEg0bmxEUUFWME9MS2ZXdnQwYUJpOTl0aVVCZWVJemhlZw?oc=5","Wed, 30 Sep 2026 02:35:35 GMT","Abeona Therapeutics SVP sells $34,681 in company stock By Investing.com Investing.com Canada","Investing.com Canada",{"title":222,"link":223,"pubDate":224,"description":225,"source":226},"Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-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?oc=5","Fri, 02 Oct 2026 11:44:25 GMT","Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times","The Manila Times",{"title":228,"link":229,"pubDate":230,"description":231,"source":232},"Abeona Therapeutics Officer Madhav Vasanthavada Files Form 144 to Sell 4,902 Shares - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxNZnNDWTlZaXdHb1RVU0ExTDZlTW9qTW8tR0U2U1VRQWFxNzRmNjItLUlmdlRtamtSMERQWlNRVmZySW9kY2diTURVOGdhS3pNQVM5dVBHZmlkVG1DdGtEdmgwMjdyQmEtd3dKY2xDT3l0ZDZTX25yYzh3ZVpDeXZON1RwNVJ2NUV1SEx1cHJLUS1mTEdVdVJCQmVqal9VLWN5aEIwSjUyOUZsbHF4WThaaXRLMXMtUU9MTnY5Y1YzbTJNU2RTLWRpUg?oc=5","Tue, 29 Sep 2026 22:32:21 GMT","Abeona Therapeutics Officer Madhav Vasanthavada Files Form 144 to Sell 4,902 Shares Kalkine Media","Kalkine Media",{"title":234,"link":235,"pubDate":207,"description":236,"source":185},"To cover stock-award taxes, Abeona Therapeutics (ABEO) CFO sells 9,191 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOd0FYbGU3b3B0OVJKTWRZNEZHdHc2Z3BaSmd1aHA2dTM2YkJMODNGTjR3VXR1TEpPSnMzRE1IbWU4NG9XcW1yaG5ZSUtUeWtRcHVJeVpTSm1kaHBTSVByRlExUHRBWk1fWDY0aW1zcUVTYjR5MVZOazg5LTVPVUg0NXVweHhDUjhWdzlNbGFRRkJwR2w5RHhoeDJ4Y3ZqOUtzeWhaR1RqaGpuOUhjT1pKdmtHM2FDU19R?oc=5","To cover stock-award taxes, Abeona Therapeutics (ABEO) CFO sells 9,191 shares. Stock Titan",{"title":238,"link":239,"pubDate":240,"description":241,"source":179},"ABEO 8-K & SEC Filings - Yahoo Finance - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMifEFVX3lxTE1XaFU5anVDVzRCa3h5YmlTWF9SUDlEVEVqOEN1S0VDWjBRQXRWUnl5ODlwdF9KM282Ym5UM3BYck5hTFRVREd4U3Bkd2lfYUo4Ql9aSGJ0ZG9GRTg5endQSnFuUlFCUHFFbjlBSE9yVUlLLUF6cGxNQ2dJR3U?oc=5","Fri, 25 Sep 2026 12:54:58 GMT","ABEO 8-K & SEC Filings - Yahoo Finance Yahoo! Finance Canada",{"title":243,"link":244,"pubDate":245,"description":246,"source":220},"Abeona Therapeutics CEO Seshadri sells $101,091 in shares By Investing.com - Investing.com Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOUWMzRG9pdG5CSTREMnc0NkMwMlYzblpBcXNZOUx4MmFjeXl0YWctaHlvNWNfWDY0eVdNVC1iM0JpM040Uy1SeThrM01wVXoyQm5RS0FyZVMyanVYRmFWMW5BUGdZaEMyWFRncmNoTFF1ak9hcDNyZ094eGI0QWNLekNZUmt5c1V3dXU2bjRtU1pQQUVOTEhuLVpVMHF6eVhMdDE5NFJYMDNqY2RpVk12S0RQVjRMSXc?oc=5","Wed, 30 Sep 2026 06:25:51 GMT","Abeona Therapeutics CEO Seshadri sells $101,091 in shares By Investing.com Investing.com Canada",{"title":248,"link":249,"pubDate":250,"description":251,"source":185},"Tax-related share sale: Abeona Therapeutics (ABEO) lists an officer’s shares for sale at a $34,682 value - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxNdmpGdlZFal9RZXpfTkNuejBTY0lNZnVUczdGakM1Skc4WFk4S1FoRUtqQzNwVWxBX3VaU2hLeDRMVWFyUjFGY3RkTUc3Ry12b1pNeEVLRGpXSGhTWEx3UDB2czNLeDNjOG1fRTNqLWFwY3hOanN3U0p4UXVNWGE2T3lBajlVYXV3elRGRENsQWMtWERjLTRvMzdjS3NWSm9fckE?oc=5","Tue, 29 Sep 2026 20:46:42 GMT","Tax-related share sale: Abeona Therapeutics (ABEO) lists an officer’s shares for sale at a $34,682 value Stock Titan",{"title":253,"link":254,"pubDate":255,"description":256,"source":185},"A tax-related share sale is proposed by an Abeona Therapeutics (NASDAQ: ABEO) officer - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxNQlR4WXdZakkzZDBzbUk5MTlKWTEzZGU3WENybGxaQzRSVUtEMkxDb3VzMGJ5d0FvZGtRa1laWGNnTDRhc3ZGUDM2ZHJ4a1ZQN1FZUUdsdXdsSzNRdFpiYmc2UVd1U3lJbUd2bkQzNGJ4cmJFeUR2cnljdzlnd2hjNVBORlc5NHBkbE9PcVJMeFZzamxzNHBuSTgzXzFGWVhsenc?oc=5","Tue, 29 Sep 2026 20:48:00 GMT","A tax-related share sale is proposed by an Abeona Therapeutics (NASDAQ: ABEO) officer Stock Titan",{"title":258,"link":259,"pubDate":260,"description":261,"source":185},"To cover taxes on vested stock, an Abeona Therapeutics (ABEO) officer lists shares valued at $47,385 for sale. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPMGNYM05VS0dNbF8tU05mN0hpUUhqU3RrVngyV1NwMEhjMkV3bXNWa3A2b2RvZE1VZGd6TWx6YnVtZmlVY05YbzBwUkVVNVVNV2lNR1dzVTVITEtBTk9hUWdVMXFSQkxiMVlCM0VGOEo3MUhQWU1rUTVJSUVIUDJDLWlmREFFUzFld0VBMjhlNUlOdnRmdlBHSkxEUjg1Q0VRZlE?oc=5","Tue, 29 Sep 2026 20:55:08 GMT","To cover taxes on vested stock, an Abeona Therapeutics (ABEO) officer lists shares valued at $47,385 for sale. Stock Titan"]